| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.09B | 168.56B | 159.02B | 145.74B | 116.67B | 150.23B |
| Gross Profit | 22.55B | 22.38B | 20.47B | 13.79B | 7.74B | 13.54B |
| EBITDA | 20.81B | 21.91B | 20.32B | 15.57B | 10.38B | 14.38B |
| Net Income | 6.17B | 6.50B | 5.78B | 518.00M | -2.08B | 2.54B |
Balance Sheet | ||||||
| Total Assets | 150.13B | 154.55B | 161.22B | 162.90B | 156.16B | 159.29B |
| Cash, Cash Equivalents and Short-Term Investments | 30.51B | 31.57B | 39.08B | 31.05B | 30.68B | 41.06B |
| Total Debt | 24.61B | 27.02B | 40.29B | 44.88B | 46.11B | 37.45B |
| Total Liabilities | 62.80B | 64.60B | 77.97B | 84.47B | 79.24B | 79.40B |
| Stockholders Equity | 84.75B | 87.34B | 80.71B | 75.60B | 74.23B | 77.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.41B | 14.98B | 6.39B | -14.97B | 56.00M |
| Operating Cash Flow | 0.00 | 16.78B | 20.37B | 14.05B | 3.71B | 16.79B |
| Investing Cash Flow | 0.00 | -7.58B | 1.59B | -8.99B | -20.11B | -17.57B |
| Financing Cash Flow | 0.00 | -18.35B | -8.80B | -7.62B | 3.58B | 8.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥259.75B | 8.29 | ― | 3.36% | 1.36% | 139.77% | |
79 Outperform | ¥425.69B | 11.25 | ― | 1.60% | -5.16% | 200.96% | |
75 Outperform | ¥482.17B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
71 Outperform | ¥60.22B | 5.45 | 8.48% | 4.59% | 1.04% | 18.43% | |
66 Neutral | ¥437.67B | 10.02 | 3.70% | 3.42% | 2.10% | -50.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥213.90B | 16.01 | ― | 4.77% | -3.71% | -51.81% |